---
figid: PMC7849358__177f01
figtitle: 'Learning from the worm: the effectiveness of protein-bound Moco to treat
  Moco deficiency'
organisms:
- Neurospora crassa
- Chlorophyta
- Volvox carteri
- Homo sapiens
- Mus musculus
- Bos taurus
- Escherichia coli
- Caenorhabditis elegans
- Adeno-associated virus
pmcid: PMC7849358
filename: 177f01.jpg
figlink: /pmc/articles/PMC7849358/figure/GAD348176SEWF1/
number: F1
caption: Diagram of Moco biosynthesis and stabilization with protein binding. The
  Moco biosynthesis pathway is conserved in eukaryotes, including C. elegans and humans.
  Loss of Moco biosynthetic enzymes results in the indicated types of Moco deficiency
  (MoCD). Free, unbound Moco is unstable but is stabilized when bound to proteins
  (e.g. sulfite oxidase).  showed that dietary supplementation with protein-bound
  Moco was an effective treatment for Moco deficiency in C. elegans. (MOCS1/MOCS2)
  Molybdenum cofactor synthesis enzymes, (Geph-G) gephyrin G-domain, (Geph-E) gephyrin
  E-domain (human; orange text), (MOC-1,2,3,4,5) molybdenum cofactor biosynthesis
  enzymes (C. elegans; green text), (GTP) guanosine triphosphate, (cPMP) cyclic pyranopterin
  monophosphate, (MPT) molybdopterin, (MPT-AMP) adenylated molybdopterin, (Moco) molybdenum
  cofactor.
papertitle: 'Learning from the worm: the effectiveness of protein-bound Moco to treat
  Moco deficiency.'
reftext: Aileen K. Sewell, et al. Genes Dev. 2021 Feb 1;35(3-4):177-179.
year: '2021'
doi: 10.1101/gad.348176.120
journal_title: Genes & Development
journal_nlm_ta: Genes Dev
publisher_name: Cold Spring Harbor Laboratory Press
keywords: molybdenum cofactor | sulfite oxidase | C. elegans | E. coli
automl_pathway: 0.8962385
figid_alias: PMC7849358__F1
figtype: Figure
organisms_ner:
- Caenorhabditis elegans
redirect_from: /figures/PMC7849358__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7849358__177f01.html
  '@type': Dataset
  description: Diagram of Moco biosynthesis and stabilization with protein binding.
    The Moco biosynthesis pathway is conserved in eukaryotes, including C. elegans
    and humans. Loss of Moco biosynthetic enzymes results in the indicated types of
    Moco deficiency (MoCD). Free, unbound Moco is unstable but is stabilized when
    bound to proteins (e.g. sulfite oxidase).  showed that dietary supplementation
    with protein-bound Moco was an effective treatment for Moco deficiency in C. elegans.
    (MOCS1/MOCS2) Molybdenum cofactor synthesis enzymes, (Geph-G) gephyrin G-domain,
    (Geph-E) gephyrin E-domain (human; orange text), (MOC-1,2,3,4,5) molybdenum cofactor
    biosynthesis enzymes (C. elegans; green text), (GTP) guanosine triphosphate, (cPMP)
    cyclic pyranopterin monophosphate, (MPT) molybdopterin, (MPT-AMP) adenylated molybdopterin,
    (Moco) molybdenum cofactor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - moc-5
  - mocs-1
  - moc-3
  - moc-2
  - moc-1
---
